RE:RE:Hospitals slow to start up againHi doc, I know you are concerned with what appears to be our main competitor, Ketruda. While it is currently about the only alternitive from what an oncologist told my nextdoor neighbor's family, the side effects can be absolutely brutal to the point of, is it worth going through to live a few extra months, plus the treatment is extremely expensive. $12 K per treatment every 3 weeks = over $200 K per/year and doesn't cure anything, but can extent life for several usually very uncomfortable months. Compare that with TLT's outpatient, usually painless treatment. If given the choice and proper description of both, and I can't understand how anyone would not chose TLT's ACT.
Add to that the fact that with Theralase CR usually follows, the decision becomes a very simple one.